Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System
Cerus Corporation (Nasdaq: CERS) announced today the signing of a new, four-year supply agreement with tablissement Franais du Sang (EFS), the French Blood Establishment, for the INTERCEPT Blood...